Miranda Murray

1.7k total citations
29 papers, 810 citations indexed

About

Miranda Murray is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Miranda Murray has authored 29 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 9 papers in Virology and 6 papers in Epidemiology. Recurrent topics in Miranda Murray's work include HIV/AIDS Research and Interventions (20 papers), HIV/AIDS drug development and treatment (13 papers) and HIV Research and Treatment (9 papers). Miranda Murray is often cited by papers focused on HIV/AIDS Research and Interventions (20 papers), HIV/AIDS drug development and treatment (13 papers) and HIV Research and Treatment (9 papers). Miranda Murray collaborates with scholars based in United Kingdom, United States and Spain. Miranda Murray's co-authors include Michael T. Halpern, Ilo E. Leppik, Deanna Kerrigan, Andrea Mantsios, David M. Margolis, Yogesh Punekar, S. Wilson Beckham, Annemiek de Ruiter, Corklin Steinhart and Cody Patton and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Ophthalmology.

In The Last Decade

Miranda Murray

28 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Miranda Murray United Kingdom	15	573	300	277	132	126	29	810
Umaporn Siangphoe United States	22	603 1.1×	420 1.4×	280 1.0×	32 0.2×	54 0.4×	47	1.1k
Gary Sinclair United States	11	572 1.0×	268 0.9×	240 0.9×	20 0.2×	93 0.7×	20	918
Shelly Sun United States	14	417 0.7×	143 0.5×	259 0.9×	22 0.2×	51 0.4×	23	660
Birgit Kvinesdal Denmark	14	308 0.5×	215 0.7×	202 0.7×	20 0.2×	23 0.2×	35	754
Renate Strehlau South Africa	21	800 1.4×	515 1.7×	177 0.6×	23 0.2×	80 0.6×	84	1.2k
Lillian Lourenço Canada	14	479 0.8×	163 0.5×	411 1.5×	29 0.2×	11 0.1×	21	722
Cristiane Aparecida Menezes de Pádua Brazil	12	226 0.4×	61 0.2×	102 0.4×	21 0.2×	41 0.3×	61	505
Carlin Rafie United States	10	351 0.6×	168 0.6×	293 1.1×	9 0.1×	58 0.5×	19	670
Markus Backmund Germany	24	271 0.5×	54 0.2×	1.7k 6.2×	46 0.3×	79 0.6×	53	2.2k
Deborah Goldstein United States	12	213 0.4×	148 0.5×	127 0.5×	27 0.2×	13 0.1×	22	527

Countries citing papers authored by Miranda Murray

Since Specialization

Citations

This map shows the geographic impact of Miranda Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda Murray more than expected).

Fields of papers citing papers by Miranda Murray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miranda Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda Murray. The network helps show where Miranda Murray may publish in the future.

Co-authorship network of co-authors of Miranda Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Miranda Murray. A scholar is included among the top collaborators of Miranda Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miranda Murray. Miranda Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Murray, Miranda, et al.. (2025). Potential Eye Disorders in People With and Without Type 2 Diabetes Mellitus Exposed to GLP-1 Receptor Agonists: An Examination of the FAERS (FDA Adverse Event Reporting System) Database. American Journal of Ophthalmology. 283. 279–290.

Mantsios, Andrea, Miranda Murray, Tahilin Sanchez Karver, et al.. (2021). Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials. BMC Health Services Research. 21(1). 255–255. 34 indexed citations

Anderson, Sarah‐Jane, Miranda Murray, David Cella, et al.. (2021). Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals. Patient. 15(1). 131–143. 2 indexed citations

Kerrigan, Deanna, Miranda Murray, Tahilin Sanchez Karver, et al.. (2020). Feasibility of Implementing Long-Acting Injectable Antiretroviral Therapy to Treat HIV: A Survey of Health Providers from the 13 Countries Participating in the ATLAS-2M Trial. AIDS Research and Human Retroviruses. 37(3). 207–213. 4 indexed citations

Kerrigan, Deanna, Tahilin Sanchez Karver, Jessie Mbwambo, et al.. (2020). “A dream come true”: Perspectives on long-acting injectable antiretroviral therapy among female sex workers living with HIV from the Dominican Republic and Tanzania. PLoS ONE. 15(6). e0234666–e0234666. 38 indexed citations

Benning, Lorie, Andrea Mantsios, Deanna Kerrigan, et al.. (2020). Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy. BMC Women s Health. 20(1). 152–152. 28 indexed citations

Mantsios, Andrea, Miranda Murray, Tahilin Sanchez Karver, et al.. (2020). Efficacy and Freedom: Patient Experiences with the Transition from Daily Oral to Long-Acting Injectable Antiretroviral Therapy to Treat HIV in the Context of Phase 3 Trials. AIDS and Behavior. 24(12). 3473–3481. 35 indexed citations

Davis, Wendy, Andrea Mantsios, Tahilin Sanchez Karver, et al.. (2020). “It made me more confident that I have it under control”: Patient and provider perspectives on moving to a two-drug ART regimen in the United States and Spain. PLoS ONE. 15(5). e0232473–e0232473. 8 indexed citations

Murray, Miranda, et al.. (2019). PIH62 INVESTIGATING THE RESPONSIVENESS TO CHANGE OF THE HIV TREATMENT SATISFACTION QUESTIONNAIRE CHANGE VERSION (HIVTSQC) IN OVERCOMING CEILING EFFECTS IN THE HIV TREATMENT SATISFACTION QUESTIONNAIRE STATUS VERSION (HIVTSQS). Value in Health. 22. S638–S639. 3 indexed citations

10.

Murray, Miranda, Martin Markowitz, Ian Frank, et al.. (2018). Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial. HIV Clinical Trials. 19(4). 129–138. 54 indexed citations

11.

Chawla, Anita, Christina Wang, Cody Patton, et al.. (2018). A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population. Infectious Diseases and Therapy. 7(2). 183–195. 115 indexed citations

12.

Proudfoot, Clare, Peter Ackerman, Cyril Llamoso, et al.. (2018). 547. Results of Patient-Reported Outcome Data From the Phase III BRIGHTE Study of Fostemsavir. Open Forum Infectious Diseases. 5(suppl_1). S203–S203. 1 indexed citations

13.

Kerrigan, Deanna, Andrea Mantsios, Robert M. Grant, et al.. (2017). Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States. AIDS and Behavior. 22(11). 3540–3549. 45 indexed citations

14.

Murray, Miranda, et al.. (2016). Psychometric Evaluation Of The Revised Hiv Treatment Satisfaction Questionnaire (Hivtsq). Value in Health. 19(7). A420–A420. 12 indexed citations

15.

Gazzard, Brian, Shehzad Ali, Axel Mühlbacher, et al.. (2014). Patient preferences for characteristics of antiretroviral therapies: results from five European countries. Journal of the International AIDS Society. 17(4S3). 19540–19540. 14 indexed citations

16.

Wild, D, Miranda Murray, & Christina Donatti. (2009). Patient perspectives on taking vitamin K antagonists: a qualitative study in the UK, USA and Spain. Expert Review of Pharmacoeconomics & Outcomes Research. 9(5). 467–474. 19 indexed citations

17.

Wild, D, et al.. (2008). Patient-reported treatment satisfaction measures for long-term anticoagulant therapy. Expert Review of Pharmacoeconomics & Outcomes Research. 8(3). 291–299. 13 indexed citations

18.

Halpern, Michael T., Anne M. Rentz, & Miranda Murray. (2000). Cost of Illness of Epilepsy in the US: Comparison of Patient-Based and Population-Based Estimates. Neuroepidemiology. 19(2). 87–99. 36 indexed citations

19.

Murray, Miranda, Michael T. Halpern, & Ilo E. Leppik. (1996). Cost of refractory epilepsy in adults in the USA. Epilepsy Research. 23(2). 139–148. 90 indexed citations

20.

Revicki, Dennis A. & Miranda Murray. (1994). Assessing Health-Related Quality of Life Outcomes of Drug Treatments for Psychiatric Disorders. CNS Drugs. 1(6). 465–476. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact